MedTrace Logo

New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs

NCT06373822 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-04-22

No results posted yet for this study

Summary

Objectives:

To identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods

Hypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease

Study Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.

Conditions

  • Adenomyosis

Interventions

DIAGNOSTIC_TEST

Circulating-mirna

A single blood sample (1 tube of 10 ml) on the day of the patient's visit to the service de Gynécologie of the CUSL.

Sponsors & Collaborators

  • Université Catholique de Louvain

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-21
Primary Completion
2031-09-30
Completion
2031-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06373822 on ClinicalTrials.gov